NNVC — NanoViricides Balance Sheet
0.000.00%
Last trade - 00:00
- $12.96m
- $7.71m
- 24
- 37
- 28
- 20
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.56 | 13.7 | 20.5 | 14.1 | 8.15 |
Prepaid Expenses | |||||
Total Current Assets | 2.83 | 14 | 20.8 | 14.4 | 8.45 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.2 | 9.54 | 9.08 | 8.69 | 8.11 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 13.4 | 23.9 | 30.3 | 23.5 | 16.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.85 | 2.16 | 0.351 | 0.413 | 0.534 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.85 | 2.16 | 0.351 | 0.413 | 2.03 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 10.6 | 21.8 | 29.9 | 23.1 | 14.9 |
Total Liabilities & Shareholders' Equity | 13.4 | 23.9 | 30.3 | 23.5 | 16.9 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |